Purpose/objective: Stereotactic radiosurgery of brain metastases requires highly conformal dose distributions. Besides beams setup, characteristics of the linear accelerator collimator may also play a role. In this study we compared the impact of leaf width on the dose outside the target for stereotactic radiosurgery of single brain metastases. Results: The mean dose was evaluated in the first 2 rings of 5 mm around the PTV(table 1). The difference in mean dose for the small lesions(Dpres=24 Gy) of the first ring of 5 mm is 1.8 Gy in favor of the Agility and 0.9 Gy for the larger lesions(Dpres=18 Gy)also in favor of the Agility. The difference is smaller for the larger lesions (figure1). Also for the second ring of 5 mm, adjacent to the first ring, the difference is is 1.1 Gy vs 0.8 Gy also in favor of the Agility. Conclusion: For the small lesions with a volume smaller than 4 cm³ the Agility shows a steeper gradient in the two surrounding rings than the MLCi1. Therefore we recommend the use of the Agility for treating the smaller lesions.
a b s t r a c t: Objective: To study the impact of target volume changes in brain metastases during fractionated stereotactic radiosurgery (fSRS) and identify patients that benefit from MRI guidance. Material and methods: For 15 patients (18 lesions) receiving fSRS only (fSRSonly) and 19 patients (20 lesions) receiving fSRS postoperatively (fSRSpostop), a treatment planning MRI (MR0) and repeated MRI during treatment (MR1) were acquired. The impact of target volume changes on the target coverage was analyzed by evaluating the planned dose distribution (based on MR0) on the planning target volume (PTV) during treatment as defined on MR1. The predictive value of target volume changes before treatment (using the diagnostic MRI (MRD)) was studied to identify patients that experienced the largest changes during treatment. Results: Target volume changes during fSRS did result in large declines of the PTV dose coverage up to 34.8% (median = 3.2%) for fSRSonly patients. For fSRSpostop the variation and declines were smaller (median PTV dose coverage change = 0.5% (4.5% to 1.9%)). Target volumes changes did also impact the minimum dose in the PTV (fSRSonly; 2.7 Gy (16.5 to 2.3 Gy), fSRSpostop; 0.4 Gy (4.2 to 2.5 Gy)). Changes in target volume before treatment (i.e. seen between the MRD and MR0) predicted which patients experienced the largest dose coverage declines during treatment. Conclusion: Target volume changes in brain metastases during fSRS can result in worsening of the target dose coverage. Patients benefiting the most from a repeated MRI during treatment could be identified before treatment.
LINK
Stereotactische radiotherapie van wervelmetastasen vereist een hoge precisie in alle stappen van de behandeling. Deze techniek werd in het VU medisch centrum in 2009 geïntroduceerd. Data met betrekking tot de behandeling van de eerste 17 klinische patiënten is geëvalueerd. Deze patiënten werden behandeld op een Novalis Tx versneller die beschikt over zowel een kilovolt (kV) cone beam CT (CBCT) scan als het ExacTrac® kV röntgensysteem. De gebruikte methode van de verschillende beeldmodaliteiten voor positionering en verificatie, de behandelingstijd en de intrafractie beweging worden in dit artikel beschreven.
